Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_2

50%

Ph phase_3

33%

Ph early_phase_1

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Early Phase 1First-in-human

1(16.7%)

Phase 2Efficacy & side effects

3(50.0%)

Phase 3Large-scale testing

2(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Other(2)

Detailed Status

Completed4

unknown2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Early Phase 11 (16.7%)

Phase 23 (50.0%)

Phase 32 (33.3%)

Trials by Status

completed467%

unknown233%

Recent Activity

0 active trials

Showing 5 of 6

completedphase_2

Pilot of a Prebiotic and Probiotic Trial in Young Infants With Severe Acute Malnutrition

NCT03666572

unknownphase_2

Pain and Magnesium

NCT03063931

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT01602185Phase 2

Study of NMDA Antagonists and Neuropathic Pain

Completed

NCT04265053Early Phase 1

Human Cerebral Blood Flow Regulation

Completed

NCT05734612Phase 3

The Role of Colchicine in Reducing The Rate of Myocardial Reperfusion Injury

Unknown

NCT03666572Phase 2

Pilot of a Prebiotic and Probiotic Trial in Young Infants With Severe Acute Malnutrition

Pain and Magnesium

Prophylaxis of Neuropathic Pain by mémantine

Completed

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6